Apollo Endosurgery, Inc. (APEN): Price and Financial Metrics

Apollo Endosurgery, Inc. (APEN): $10.00

0.08 (+0.81%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

APEN Price/Volume Stats

Current price $10.00 52-week high $10.30
Prev. close $9.92 52-week low $3.49
Day low $9.92 Volume 1,658,800
Day high $10.00 Avg. volume 1,432,125
50-day MA $9.91 Dividend yield N/A
200-day MA $7.43 Market Cap 579.72M

APEN Stock Price Chart Interactive Chart >


Apollo Endosurgery, Inc. (APEN) Company Bio


Apollo Endosurgery, Inc. focuses on the design, development, and commercialization of medical devices for the treatment of obesity. The company offers endo-bariatric products, such as Orbera intragastric balloon system, a non-surgical alternative for the treatment of overweight and obese adults; and OverStitch, an endoscopic suturing system that enables endoscopic procedures by allowing physicians to place full-thickness sutures and secure the approximation of tissue through an Olympus dual-channel flexible endoscope. It also provides surgical products, including Lap-Band system, a system designed to provide minimally invasive long-term treatment of obesity; and accessories used in laparoscopic bariatric surgeries. The company is based in Austin, Texas.


APEN Latest News Stream


Event/Time News Detail
Loading, please wait...

APEN Latest Social Stream


Loading social stream, please wait...

View Full APEN Social Stream

APEN Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year 250.88%
YTD N/A
2023 0.00%
2022 18.27%
2021 147.94%
2020 19.30%
2019 -17.39%

Continue Researching APEN

Want to see what other sources are saying about Apollo Endosurgery Inc's financials and stock price? Try the links below:

Apollo Endosurgery Inc (APEN) Stock Price | Nasdaq
Apollo Endosurgery Inc (APEN) Stock Quote, History and News - Yahoo Finance
Apollo Endosurgery Inc (APEN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!